<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01081457</url>
  </required_header>
  <id_info>
    <org_study_id>2008/163/HP</org_study_id>
    <nct_id>NCT01081457</nct_id>
  </id_info>
  <brief_title>Effect of Deep Brain Stimulation on Gastrointestinal (GI) Motility</brief_title>
  <acronym>SCP-Comodig</acronym>
  <official_title>Effect of Deep Brain Stimulation on Voluntary and Involuntary Gastrointestinal Motility in Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Rouen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Rouen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Parkinson's disease is characterized by extra-pyramidal symptoms as well as digestive&#xD;
      involvement with gastrointestinal motility (GI) impairment. Deep brain stimulation has been&#xD;
      recently developed as a successful treatment for extrapyramidal symptoms. In addition,&#xD;
      preliminary reports suggest that this therapy might be successful to relieve GI symptoms as&#xD;
      well. The aim of this study is therefore to assess the effect of deep brain stimulation on GI&#xD;
      voluntary as well as involuntary motility.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anal pressure</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Parkinson's Disease</condition>
  <arm_group>
    <arm_group_label>ON</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stimulator switched ON</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OFF</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Stimulator switched OFF</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Deep brain stimulation</intervention_name>
    <description>Comparison ON vs OFF</description>
    <arm_group_label>OFF</arm_group_label>
    <arm_group_label>ON</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient over 18 yo&#xD;
&#xD;
          -  patient with Parkinson's disease implanted for deep brain stimulation&#xD;
&#xD;
          -  patient responders to deep brain stimulation (UPDRS improved by at least 40%)&#xD;
&#xD;
          -  patient covered by the french health care system&#xD;
&#xD;
          -  patient not taking anti-parkinsonian medication the day before evaluation&#xD;
&#xD;
          -  French speaking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient below 18 yo&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  Severe psychiatric or cognitive disorders&#xD;
&#xD;
          -  diabetes mellitus&#xD;
&#xD;
          -  morbid obesity&#xD;
&#xD;
          -  compulsive eating disorders&#xD;
&#xD;
          -  diffuse GI motility impairment (except Parkinson's disease)&#xD;
&#xD;
          -  other evolutive neurologic disorders&#xD;
&#xD;
          -  previous history of significant GI resection&#xD;
&#xD;
          -  inability to swallow or defecate when asked&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rouen University Hospital</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <study_first_submitted>March 4, 2010</study_first_submitted>
  <study_first_submitted_qc>March 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2010</study_first_posted>
  <last_update_submitted>February 6, 2012</last_update_submitted>
  <last_update_submitted_qc>February 6, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Rouen</investigator_affiliation>
    <investigator_full_name>Guillaume GOURCEROL</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Parkinson's disease</keyword>
  <keyword>deep brain stimulation</keyword>
  <keyword>GI motility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

